Pharmaceutical
Survey Snapshot
Revenue Growth Expectations in the
Pharmaceutical Industry - 2012–2013:
Survey Snapshot
Reference code: SR430SS
Published: June 2012
ICD Research
John Carpenter House
7 Carmelite Street
London EC4Y 0BS
United Kingdom
Tel: +44 (0) 20 7936 6400
Fax: +44 (0) 20 7336 6813
Website: www.icd-research.com
www.icd-research.com
TABLE OF CONTENTS
TABLE OF CONTENTS
1 Introduction ........................................................................................................................... 5
1.1 What is This Report About? ............................................................................................................. 5
1.2 Definitions ........................................................................................................................................ 5
1.3 Methodology .................................................................................................................................... 6
1.4 Profile of Survey Respondents: Global Pharmaceutical Industry ...................................................... 8
1.4.1 Profile of buyer respondents: global pharmaceutical industry .................................................................... 8
1.4.2 Profile of supplier respondents: global pharmaceutical industry ................................................................ 9
2 Revenue Growth Expectations in the Global Pharmaceutical Industry ......................... 11
2.1 Global pharmaceutical industry: revenue growth expectations by company type.............................13
2.2 Global pharmaceutical industry: revenue growth expectations by region .........................................15
2.3 Global pharmaceutical industry: revenue growth expectations by turnover......................................17
2.4 Global pharmaceutical industry: revenue growth expectations by senior level respondents ............18
2.5 Global pharmaceutical industry: Revenue growth expectations-cross industry comparisons ...........19
3 Appendix .............................................................................................................................. 20
3.1 Global Pharmaceutical Industry Survey Results – Closed Questions ..............................................20
3.2 Methodology ...................................................................................................................................35
3.3 Contact us .......................................................................................................................................35
3.4 About ICD Research .......................................................................................................................35
3.5 Disclaimer .......................................................................................................................................35
Revenue Growth Expectations in the Pharmaceutical Industry - 2012–2013: Survey Snapshot Page 2
© ICD Research. This product is licensed and is not to be photocopied Published: June 2012
TABLE OF CONTENTS
LIST OF FIGURES
Figure 1: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010–2012 ...................................................................................... 12
Figure 2: Global Pharmaceutical Industry Revenue Growth Optimism by Company Type(%), 2010–2012 .......................................................... 14
Figure 3: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010–2012 ..................................................................... 16
Figure 4: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012 ............................................................................ 17
Figure 5: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012 ....................................................................... 18
Figure 6: Revenue Growth Optimism: Cross Industry Comparison (%), 2012 ..................................................................................................... 19
Revenue Growth Expectations in the Pharmaceutical Industry - 2012–2013: Survey Snapshot Page 3
© ICD Research. This product is licensed and is not to be photocopied Published: June 2012
TABLE OF CONTENTS
LIST OF TABLES
Table 1: Total Global Pharmaceutical Industry Survey Respondents by Company Type, 2012 ............................................................................. 8
Table 2: Global Pharmaceutical Industry Buyer Respondents by Job Role (%), 2012 ........................................................................................... 9
Table 3: Global Pharmaceutical Industry Buyer Respondents by Company Turnover (%), 2012 ........................................................................... 9
Table 4: Global Pharmaceutical Industry Buyer Respondents by Region (%), 2012 .............................................................................................. 9
Table 5: Global Pharmaceutical Industry Supplier Respondents by Job Role (%), 2012 ..................................................................................... 10
Table 6: Global Pharmaceutical Industry Supplier Respondents by Company Turnover (%), 2012 ..................................................................... 10
Table 7: Global Pharmaceutical Industry Supplier Respondents by Region (%), 2012 ........................................................................................ 10
Table 8: Global Pharmaceutical Industry Revenue Growth Optimism (%), 2010–2012 ....................................................................................... 12
Table 9: Global Pharmaceutical Industry Revenue Growth Optimism by Buyers (%), 2010–2012 ....................................................................... 14
Table 10: Global Pharmaceutical Industry Revenue Growth Optimism by Region (%), 2010–2012..................................................................... 15
Table 11: Global Pharmaceutical Industry Revenue Growth Optimism by Turnover (%), 2012 ........................................................................... 17
Table 12: Global Pharmaceutical Industry Revenue Growth Optimism by Senior Level (%), 2012 ...................................................................... 18
Table 13: Survey Results - Closed Questions ..................................................................................................................................................... 20
Revenue Growth Expectations in the Pharmaceutical Industry - 2012–2013: Survey Snapshot Page 4
© ICD Research. This product is licensed and is not to be photocopied Published: June 2012
INTRODUCTION
1 Introduction
1.1 What is This Report About?
This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading
pharmaceutical industry companies. As numerous countries recover from the effects of recession, this report
provides the reader with a definitive analysis of industry outlook and explores how opportunities and demand
are set to change in 2012–2013. Further, this report not only grants access to the opinions and strategies of
business decision makers and competitors, but also examines their actions concerning business priorities.
The report also examines:
Revenue growth expectations: projects revenue growth expectations of major industry stakeholders
Market-specific growth opportunities: identifies top growth regions in order that companies can allocate
their marketing activities and budgets effectively
Mergers and acquisitions: expectations surrounding merger and acquisition activity and core influencing
factors
Leading business concerns: identifies leading business concerns and subsequent efforts to negate them
Procurement expenditure trends: tracks the procurement budgets of buyer companies and forecasts the
possible change in spend.
Factors for supplier selection: understands critical factors influencing supplier selection
1.2 Definitions
Active pharmaceutical ingredients (API): An active ingredient (AI) is the substance in a pharmaceutical
drug or a pesticide that is biologically active.
Excipient: An excipient is generally a pharmacologically inactive substance used as a carrier for the active
ingredients of a medication.
Patent: It is a set of exclusive rights granted by a state (national government) to an inventor or their
assignee for a limited period of time in exchange for a public disclosure of an invention.
Contract manufacturing organization (CMO): CMO is an organization that serves the pharmaceutical
industry and provides clients with comprehensive services such as drug development and manufacturing.
Services offered by CMOs include, but are not limited to: pre-formulation, formulation development, stability
studies, method development, pre-clinical and Phase I clinical trial materials, late-stage clinical trial
materials, formal stability, scale-up, registration batches and commercial production.
Contract research organization (CRO): Also called a clinical research organization, a CRO is a service
organization that provides support to the pharmaceutical and bio-technology industries in the form of
outsourced pharmaceutical research services, for both drugs and medical devices. CROs range from large,
international full service organizations to small, niche specialty groups and can offer their clients the
experience of moving a new drug or device from its conception to FDA/EMA marketing approval without the
drug sponsor having to maintain a staff for these services
Revenue Growth Expectations in the Pharmaceutical Industry - 2012–2013: Survey Snapshot Page 5
© ICD Research. This product is licensed and is not to be photocopied Published: June 2012
INTRODUCTION
Company turnover: Companies with turnover of less than US$100 million are identified in the report as
small companies. Companies with turnover between US$100 million–US$1 billion are referred to as medium
sized companies and those with turnover of more than US$1 billion as large companies.
E-procurement (electronic procurement): business-to-business (B2B) buying and selling of services
through the internet and other IT solutions, such as electronic data interchange (EDI) and enterprise
resource planning (ERP).
1.3 Methodology
1) Online Survey
The research source in this report is based on the surveyed opinions and forward-looking expectations of
highly engaged and senior industry professionals. ICD Research conducted an extensive online survey during
December 2011 taken by 247 senior global industry buyers and suppliers. These respondents cover C-levels,
directors, managers and technical and professional staff.
These respondents are drawn from the ICD Research Industry Insight Panel, an exclusive